WO2019008679A1 - Simulate biological sample - Google Patents

Simulate biological sample Download PDF

Info

Publication number
WO2019008679A1
WO2019008679A1 PCT/JP2017/024533 JP2017024533W WO2019008679A1 WO 2019008679 A1 WO2019008679 A1 WO 2019008679A1 JP 2017024533 W JP2017024533 W JP 2017024533W WO 2019008679 A1 WO2019008679 A1 WO 2019008679A1
Authority
WO
WIPO (PCT)
Prior art keywords
shape
simulation sample
biological
tissue
biological simulation
Prior art date
Application number
PCT/JP2017/024533
Other languages
French (fr)
Japanese (ja)
Inventor
裕基 庄野
成田 利治
明日香 向井
遼佑 伊藤
Original Assignee
オリンパス株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オリンパス株式会社 filed Critical オリンパス株式会社
Priority to PCT/JP2017/024533 priority Critical patent/WO2019008679A1/en
Priority to PCT/JP2018/025179 priority patent/WO2019009279A1/en
Publication of WO2019008679A1 publication Critical patent/WO2019008679A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine

Definitions

  • the present invention relates to a biological simulation sample, and more particularly to a biological simulation sample for fluorescence observation.
  • a method of injecting a fluorescent dye such as indocyanine green (ICG) into a patient and measuring the fluorescence intensity from the fluorescent dye in blood is known as a means for determining the presence or absence of blood flow in living tissue.
  • a standard sample that emits fluorescence of known intensity is used to standardize the measured intensity of fluorescence (see, for example, Patent Documents 1 and 2).
  • Patent Documents 1 and 2 are not suitable for use as simulated samples for performance evaluation and demonstration of endoscopes. That is, in the performance evaluation and demonstration of the endoscope, while using a simulated sample instead of the living tissue in the living body, the appearance of the fluorescence from the living tissue in the image acquired by the endoscope in the clinical scene is as real as possible It is required to reproduce in However, since the standard samples of Patent Documents 1 and 2 do not simulate living tissue, they can not achieve a near-visible appearance of fluorescence from living tissue in a clinical setting.
  • the present invention has been made in view of the above-described circumstances, and it is an object of the present invention to provide a biological simulation sample capable of realizing the appearance close to the appearance of fluorescence from biological tissue in a clinical situation.
  • One aspect of the present invention is a first member containing a fluorescent material and simulating the shape of a living tissue to be observed, and a second member covering the first member and simulating the optical characteristics of the surrounding tissue of the living tissue to be observed And a biological simulation sample comprising
  • the shape of the living tissue to be observed is simulated by the first member, and the optical property of the peripheral tissue to be observed is simulated by the second member around the first member. Therefore, by irradiating the biological simulation sample with excitation light to cause the fluorescent material contained in the first member to emit light, it is possible to realize a near-visible appearance of fluorescence from biological tissue in a clinical situation.
  • the second member has a layer structure in which two or more layers are stacked, and the two or more layers are different from each other in at least one of the light scattering property and the light absorption property. Good.
  • Such a second member more realistically simulates the optical characteristics of the surrounding tissue having a layered structure. This makes it possible to achieve a view closer to the view of the living tissue to be observed in the surrounding tissue having a layered structure.
  • the first member may simulate the shape of a vessel, for example, the running shape of a blood vessel or the shape of a lymphatic vessel. In this way, a closer view of fluorescence from vessels such as blood vessels or lymph vessels in a clinical setting can be realized by the first member simulating the shape of the vessel.
  • the fluorescent material may be indocyanine green (ICG).
  • ICG indocyanine green
  • ICG is often used for fluorescence observation of vessels in the clinic. Therefore, a closer view of the fluorescence from vessels in a clinical setting can be achieved by the first member including the ICG.
  • the first member is made of a gel material containing a fluorescent material
  • the second member is made of a cured resin material
  • the first member is embedded in the second member. It is also good.
  • a gel material that can be shaped into any shape, various biological tissue shapes can be simulated by the first member.
  • the gel material can be prevented from drying and the biological simulation sample can be stored for a long time.
  • ADVANTAGE OF THE INVENTION According to this invention, it is effective in the ability to implement
  • FIG. 1A It is a perspective view of a living body simulation sample concerning one embodiment of the present invention. It is a side view of the biological simulation sample of FIG. 1A. It is a top view of the living body simulation sample which shows the modification of the shape of the 1st member of Drawing 1A. It is a top view of the living body simulation sample which shows the other modification of the shape of the 1st member of Drawing 1A. It is a perspective view of the modification of a living body simulation sample of Drawing 1A. It is a side view of a living body simulation sample of Drawing 4A. It is a perspective view of the other modification of the biological simulation sample of FIG. 1A.
  • the living body simulation sample 1 is used as a subject instead of a living tissue in a living body in the evaluation and demonstration of the image performance of an endoscope.
  • the biological simulation sample 1 includes the first member 2 simulating the shape of the biological tissue to be observed, and the optical characteristics of the surrounding tissue of the biological tissue to be observed covering the first member 2 And a second member 3 that simulates.
  • the first member 2 is made of a gel material containing indocyanine green (ICG).
  • ICG indocyanine green
  • a gel material for example, an agar gel, a gelatin gel, a two-component mixed gel, or the like is used.
  • the first member 2 has a shape that simulates the traveling shape of a blood vessel to be observed.
  • the first member 2 has a branch structure in which branching from one linear structure to a plurality of linear structures is repeated. In FIG. 1A, the shape of the first member 2 is simplified.
  • the second member 3 is made of a block-like or sheet-like cured resin material, and the first member 2 is embedded in the second member 3.
  • resin material silicone resin, polyurethane resin, epoxy resin or the like is used.
  • the second member 3 is the same as or similar to the surrounding tissue to be observed in at least one of the light absorption property and the light scattering property.
  • Such a biological simulation sample 1 is manufactured, for example, by the following method.
  • the gel material is uniformly mixed with ICG, the gel material is filled in a syringe, and the gel material is discharged in a thread form from the syringe, thereby forming the gel material into a shape that simulates the traveling shape of a blood vessel.
  • a liquid resin material is poured into a mold, the entire molded gel material is placed inside the resin material, and the resin material is cured. Thereby, the biological simulation sample 1 shown in FIG. 1A is manufactured.
  • the biological simulation sample 1 is disposed to face the tip of the endoscope, the excitation light (wavelength 760 nm) is irradiated to the biological simulation sample 1 from the endoscope, and the fluorescence (wavelength) emitted from the ICG contained in the first member 2 830 nm) is observed by an endoscope.
  • an image (simulated image) simulating an image obtained by imaging fluorescence from a blood vessel in a living body to which ICG has been administered in a clinical scene is acquired by the endoscope.
  • the acquired simulated image of the biological simulation sample 1 is displayed on the display.
  • the user evaluates the imaging performance of the endoscope during clinical use based on the simulated image displayed on the display.
  • the first member 2 simulates the traveling shape of the blood vessel in the living body
  • fluorescence is emitted in the same shape as the traveling shape of the blood vessel.
  • the second member 3 around the first member 2 simulates the optical properties of the surrounding tissue of the blood vessel
  • the fluorescence emitted from the first member 2 is the same as in living tissue in the second member 3 Spread out.
  • the appearance close to the appearance of the fluorescence observed by the endoscope in the clinical scene is realized.
  • the user can accurately evaluate the appearance of fluorescence in the image when the endoscope is used clinically based on the simulated image on the display.
  • the first member 2 is made of a gel material that can be formed into an arbitrary shape, the shape of any living tissue including a living tissue having a complicated shape such as a traveling shape of a blood vessel Has the advantage of being able to simulate
  • the gel material constituting the first member 2 is not suitable for long-term storage since the characteristics change due to drying etc., the cured resin material constituting the second member 3 is stable against air and moisture. Material and suitable for long-term storage. Therefore, covering the entire first member 2 with the second member 3 has an advantage of being able to provide the biological simulation sample 1 that can be stored for a long time while maintaining the quality of the fluorescent material.
  • the first member 2 simulates the traveling shape of the blood vessel.
  • the shape of another living tissue may be simulated.
  • the first member 2 may simulate the shape of a lymphatic vessel and may simulate the shape of another vessel such as a bile duct.
  • the first member 2 may simulate the shape of a tumor.
  • ICG is used as the fluorescent material, but the type of fluorescent material is not limited to this, and other types of fluorescent materials may be used.
  • fluorescent material quantum dots or protoporphyrin IX (ppIX) may be used as the fluorescent material.
  • ppIX protoporphyrin IX
  • ppIX protoporphyrin IX
  • the single first member 2 is disposed in the second member 3 having a single-layer structure
  • the number of first members 2 and the number of layers constituting the second member 3 can be changed as appropriate.
  • the plurality of first members 21 and 22 may be disposed at mutually different depths in the second member 3 having a single-layer structure.
  • the shapes of the plurality of first members 21 and 22 may be identical to each other, or may be different from each other as shown in FIG. 4A.
  • the second member 3 may have a layered structure in which two or more layers 3 a and 3 b are stacked.
  • the 2nd member 3 of 2 layer structure is shown by FIG. 5 as an example.
  • Surrounding tissues such as blood vessels, lymph vessels, and tumors have a layered structure composed of multiple layers having different light scattering properties and light absorption properties.
  • the layers 3a and 3b of the second member 3 are different from each other in at least one of the light scattering property and the light absorption property so as to simulate the optical property of each layer (for example, the mucous layer and muscle layer) of the surrounding tissue. . This makes it possible to achieve an appearance closer to the appearance of fluorescence from the observation target in a clinical setting.
  • the layer 3a, 3b have respectively about 0.1 mm -1 or more 5 mm -1 or less of the light scattering coefficient in the wavelength range of visible light.
  • the layers 3a and 3b have light absorption characteristics that simulate the absorption spectrum of blood, and each have a light absorption coefficient of more than about 0 mm -1 and 20 mm -1 or less in the visible light wavelength range.
  • the light scattering coefficient and the light absorption coefficient of the layer 3b simulating the layer on the deep side are preferably larger than the light scattering coefficient and the light absorption coefficient of the layer 3a simulating the layer on the front surface, respectively.
  • the first member 2 may be disposed only in one layer, and is disposed between two adjacent layers. It may be provided, or may be disposed across multiple layers. Alternatively, the first member 2 may be disposed in each of the layers 3a and 3b.

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
  • Business, Economics & Management (AREA)
  • Educational Administration (AREA)
  • Educational Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Mathematical Optimization (AREA)
  • Medicinal Chemistry (AREA)
  • Mathematical Analysis (AREA)
  • Optics & Photonics (AREA)
  • Computational Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Mathematical Physics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Endoscopes (AREA)

Abstract

This simulate biological sample (1) comprises: a first member (2) that includes a fluorescent material and simulates the shape of biological tissue to be observed; and a second member (3) that covers the first member (2) and simulates the optical properties of tissue surrounding the biological tissue to be observed.

Description

生体模擬試料Biological simulation sample
 本発明は、生体模擬試料に関し、特に蛍光観察用の生体模擬試料に関するものである。 The present invention relates to a biological simulation sample, and more particularly to a biological simulation sample for fluorescence observation.
 従来、生体組織内の血流の有無を判定する手段として、インドシアニングリーン(ICG)のような蛍光色素を患者に注射し、血液内の蛍光色素からの蛍光強度を測定する方法が知られている。この方法において、蛍光の測定強度を基準化するために、既知の強度の蛍光を発する標準試料が用いられている(例えば、特許文献1,2参照。)。 Conventionally, a method of injecting a fluorescent dye such as indocyanine green (ICG) into a patient and measuring the fluorescence intensity from the fluorescent dye in blood is known as a means for determining the presence or absence of blood flow in living tissue. There is. In this method, a standard sample that emits fluorescence of known intensity is used to standardize the measured intensity of fluorescence (see, for example, Patent Documents 1 and 2).
特開2005-300540号公報JP 2005-300540 A 特開2013-96920号公報JP, 2013-96920, A
 しかしながら、特許文献1,2に開示されている標準試料は、内視鏡の性能評価やデモンストレーション用の模擬試料としての用途には適さない。すなわち、内視鏡の性能評価やデモンストレーションでは、生体内の生体組織の代わりに模擬試料を使用しつつ、臨床場面で内視鏡によって取得される画像内の生体組織からの蛍光の見えをできるだけリアルに再現することが求められる。しかしながら、特許文献1,2の標準試料は、生体組織を模擬したものではないため、臨床場面での生体組織からの蛍光の見えに近い見えを実現することができない。 However, the standard samples disclosed in Patent Documents 1 and 2 are not suitable for use as simulated samples for performance evaluation and demonstration of endoscopes. That is, in the performance evaluation and demonstration of the endoscope, while using a simulated sample instead of the living tissue in the living body, the appearance of the fluorescence from the living tissue in the image acquired by the endoscope in the clinical scene is as real as possible It is required to reproduce in However, since the standard samples of Patent Documents 1 and 2 do not simulate living tissue, they can not achieve a near-visible appearance of fluorescence from living tissue in a clinical setting.
 本発明は、上述した事情に鑑みてなされたものであって、臨床場面での生体組織からの蛍光の見えに近い見えを実現することができる生体模擬試料を提供することを目的とする。 The present invention has been made in view of the above-described circumstances, and it is an object of the present invention to provide a biological simulation sample capable of realizing the appearance close to the appearance of fluorescence from biological tissue in a clinical situation.
 上記目的を達成するため、本発明は以下の手段を提供する。
 本発明の一態様は、蛍光材料を含み観察対象の生体組織の形状を模擬した第1部材と、該第1部材を覆い前記観察対象の生体組織の周辺組織の光学特性を模擬した第2部材とを備える生体模擬試料である。
 本態様によれば、観察対象の生体組織の形状が第1部材によって模擬され、観察対象の周辺組織の光学特性が第1部材の周囲の第2部材によって模擬される。したがって、生体模擬試料に励起光を照射して第1部材に含まれる蛍光材料を発光させることで、臨床場面での生体組織からの蛍光の見えに近い見えを実現することができる。
In order to achieve the above object, the present invention provides the following means.
One aspect of the present invention is a first member containing a fluorescent material and simulating the shape of a living tissue to be observed, and a second member covering the first member and simulating the optical characteristics of the surrounding tissue of the living tissue to be observed And a biological simulation sample comprising
According to this aspect, the shape of the living tissue to be observed is simulated by the first member, and the optical property of the peripheral tissue to be observed is simulated by the second member around the first member. Therefore, by irradiating the biological simulation sample with excitation light to cause the fluorescent material contained in the first member to emit light, it is possible to realize a near-visible appearance of fluorescence from biological tissue in a clinical situation.
 上記態様においては、前記第2部材は、2以上の層が積層された層構造を有し、前記2以上の層が、光散乱特性および光吸収特性のうち少なくとも一方において相互に異なっていてもよい。
 このような第2部材によって、層構造を有する周辺組織の光学特性がよりリアルに模擬される。これにより、層構造を有する周辺組織内の観察対象の生体組織の見えにさらに近い見えを実現することができる。
In the above aspect, the second member has a layer structure in which two or more layers are stacked, and the two or more layers are different from each other in at least one of the light scattering property and the light absorption property. Good.
Such a second member more realistically simulates the optical characteristics of the surrounding tissue having a layered structure. This makes it possible to achieve a view closer to the view of the living tissue to be observed in the surrounding tissue having a layered structure.
 上記態様においては、前記第1部材が、脈管の形状、例えば、血管の走行形状またはリンパ管の形状を模擬していてもよい。
 このようにすることで、臨床場面での血管またはリンパ管のような脈管からの蛍光の見えにより近い見えを、脈管の形状を模擬した第1部材によって実現することができる。
In the above aspect, the first member may simulate the shape of a vessel, for example, the running shape of a blood vessel or the shape of a lymphatic vessel.
In this way, a closer view of fluorescence from vessels such as blood vessels or lymph vessels in a clinical setting can be realized by the first member simulating the shape of the vessel.
 上記態様においては、前記蛍光材料が、インドシアニングリーン(ICG)であってもよい。
 臨床において脈管の蛍光観察にICGが使用されることが多い。したがって、臨床場面での脈管からの蛍光の見えにより近い見えを、ICGを含む第1部材によって実現することができる。
In the above aspect, the fluorescent material may be indocyanine green (ICG).
ICG is often used for fluorescence observation of vessels in the clinic. Therefore, a closer view of the fluorescence from vessels in a clinical setting can be achieved by the first member including the ICG.
 上記態様においては、前記第1部材が、蛍光材料を含むゲル材料からなり、前記第2部材が、硬化した樹脂材料からなり、前記第1部材が、前記第2部材内に包埋されていてもよい。
 任意の形状に成形可能なゲル材料を使用することで、様々な生体組織の形状を第1部材によって模擬することができる。また、空気および湿気に対して安定である硬化した樹脂材料内にゲル材料を包埋することで、ゲル材料の乾燥を防ぎ、生体模擬試料の長期保存が可能となる。
In the above aspect, the first member is made of a gel material containing a fluorescent material, the second member is made of a cured resin material, and the first member is embedded in the second member. It is also good.
By using a gel material that can be shaped into any shape, various biological tissue shapes can be simulated by the first member. In addition, by embedding the gel material in a cured resin material that is stable against air and moisture, the gel material can be prevented from drying and the biological simulation sample can be stored for a long time.
 本発明によれば、臨床場面での生体組織からの蛍光の見えに近い見えを実現することができるという効果を奏する。 ADVANTAGE OF THE INVENTION According to this invention, it is effective in the ability to implement | achieve the appearance close | similar to the appearance of the fluorescence from the biological tissue in a clinical scene.
本発明の一実施形態に係る生体模擬試料の斜視図である。It is a perspective view of a living body simulation sample concerning one embodiment of the present invention. 図1Aの生体模擬試料の側面図である。It is a side view of the biological simulation sample of FIG. 1A. 図1Aの第1部材の形状の変形例を示す生体模擬試料の平面図である。It is a top view of the living body simulation sample which shows the modification of the shape of the 1st member of Drawing 1A. 図1Aの第1部材の形状の他の変形例を示す生体模擬試料の平面図である。It is a top view of the living body simulation sample which shows the other modification of the shape of the 1st member of Drawing 1A. 図1Aの生体模擬試料の変形例の斜視図である。It is a perspective view of the modification of a living body simulation sample of Drawing 1A. 図4Aの生体模擬試料の側面図である。It is a side view of a living body simulation sample of Drawing 4A. 図1Aの生体模擬試料の他の変形例の斜視図である。It is a perspective view of the other modification of the biological simulation sample of FIG. 1A.
 以下に、本発明の一実施形態に係る生体模擬試料1について図面を参照して説明する。
 本実施形態に係る生体模擬試料1は、内視鏡の画像性能の評価やデモンストレーションにおいて、生体内の生体組織の代わりに被写体として使用されるものである。生体模擬試料1は、図1Aおよび図1Bに示されるように、観察対象の生体組織の形状を模擬した第1部材2と、第1部材2を覆い観察対象の生体組織の周辺組織の光学特性を模擬した第2部材3とを備えている。
Hereinafter, a biological simulation sample 1 according to an embodiment of the present invention will be described with reference to the drawings.
The living body simulation sample 1 according to the present embodiment is used as a subject instead of a living tissue in a living body in the evaluation and demonstration of the image performance of an endoscope. As shown in FIGS. 1A and 1B, the biological simulation sample 1 includes the first member 2 simulating the shape of the biological tissue to be observed, and the optical characteristics of the surrounding tissue of the biological tissue to be observed covering the first member 2 And a second member 3 that simulates.
 第1部材2は、インドシアニングリーン(ICG)を含むゲル材料からなる。ゲル材料としては、例えば、寒天ゲル、ゼラチンゲル、または2液混合型ゲル等が用いられる。第1部材2は、観察対象である血管の走行形状を模擬した形状を有している。例えば、第1部材2は、1本の線状構造から複数本の線状構造への分岐を繰り返す分岐構造を有している。図1Aにおいて、第1部材2の形状は簡略化されている。 The first member 2 is made of a gel material containing indocyanine green (ICG). As a gel material, for example, an agar gel, a gelatin gel, a two-component mixed gel, or the like is used. The first member 2 has a shape that simulates the traveling shape of a blood vessel to be observed. For example, the first member 2 has a branch structure in which branching from one linear structure to a plurality of linear structures is repeated. In FIG. 1A, the shape of the first member 2 is simplified.
 第2部材3は、ブロック状またはシート状の硬化した樹脂材料からなり、第2部材3内に第1部材2が包埋されている。樹脂材料としては、シリコーン樹脂、ポリウレタン樹脂、またはエポキシ樹脂等が用いられる。第2部材3は、光吸収特性および光散乱特性のうち少なくとも一方において、観察対象の周辺組織と同一または類似している。 The second member 3 is made of a block-like or sheet-like cured resin material, and the first member 2 is embedded in the second member 3. As the resin material, silicone resin, polyurethane resin, epoxy resin or the like is used. The second member 3 is the same as or similar to the surrounding tissue to be observed in at least one of the light absorption property and the light scattering property.
 このような生体模擬試料1は、例えば、以下の方法によって製造される。
 ゲル材料にICGを均一に混合し、ゲル材料をシリンジに充填し、シリンジからゲル材料を糸状に吐出することによって、ゲル材料を血管の走行形状を模擬した形状に成形する。次に、液状の樹脂材料を鋳型内に注入し、成形されたゲル材料全体を樹脂材料の内部に配置し、樹脂材料を硬化させる。これにより、図1Aに示される生体模擬試料1が製造される。
Such a biological simulation sample 1 is manufactured, for example, by the following method.
The gel material is uniformly mixed with ICG, the gel material is filled in a syringe, and the gel material is discharged in a thread form from the syringe, thereby forming the gel material into a shape that simulates the traveling shape of a blood vessel. Next, a liquid resin material is poured into a mold, the entire molded gel material is placed inside the resin material, and the resin material is cured. Thereby, the biological simulation sample 1 shown in FIG. 1A is manufactured.
 次に、このように構成された生体模擬試料1の使用方法について説明する。
 内視鏡の先端に対向するように生体模擬試料1を配置し、内視鏡から生体模擬試料1に励起光(波長760nm)を照射し、第1部材2に含まれるICGが発する蛍光(波長830nm)を内視鏡によって観察する。これにより、臨床場面でICGを投与された生体内の血管からの蛍光を撮影した画像を模擬した画像(模擬画像)が、内視鏡によって取得される。取得された生体模擬試料1の模擬画像は、ディスプレイに表示される。ユーザは、ディスプレイに表示された模擬画像に基づいて、臨床での使用時の内視鏡の画像性能を評価する。
Next, a method of using the biological simulation sample 1 configured as described above will be described.
The biological simulation sample 1 is disposed to face the tip of the endoscope, the excitation light (wavelength 760 nm) is irradiated to the biological simulation sample 1 from the endoscope, and the fluorescence (wavelength) emitted from the ICG contained in the first member 2 830 nm) is observed by an endoscope. Thereby, an image (simulated image) simulating an image obtained by imaging fluorescence from a blood vessel in a living body to which ICG has been administered in a clinical scene is acquired by the endoscope. The acquired simulated image of the biological simulation sample 1 is displayed on the display. The user evaluates the imaging performance of the endoscope during clinical use based on the simulated image displayed on the display.
 この場合に、本実施形態によれば、第1部材2が生体内の血管の走行形状を模擬しているので、生体模擬試料1内では、血管の走行形状と同様の形状に蛍光が光る。さらに、第1部材2の周囲の第2部材3が血管の周辺組織の光学特性を模擬しているので、第1部材2から発せられた蛍光は、第2部材3内において生体組織内と同様に広がる。これにより、生体模擬試料1の模擬画像において、臨床場面で内視鏡によって観察される蛍光の見えに近い見えが実現される。したがって、ユーザは、ディスプレイ上の模擬画像に基づいて、内視鏡を臨床で使用したときの画像内の蛍光の見えを正確に評価することができる。 In this case, according to the present embodiment, since the first member 2 simulates the traveling shape of the blood vessel in the living body, in the living body simulation sample 1, fluorescence is emitted in the same shape as the traveling shape of the blood vessel. Furthermore, since the second member 3 around the first member 2 simulates the optical properties of the surrounding tissue of the blood vessel, the fluorescence emitted from the first member 2 is the same as in living tissue in the second member 3 Spread out. As a result, in the simulated image of the biological simulation sample 1, the appearance close to the appearance of the fluorescence observed by the endoscope in the clinical scene is realized. Thus, the user can accurately evaluate the appearance of fluorescence in the image when the endoscope is used clinically based on the simulated image on the display.
 また、第1部材2は、任意の形状に成形可能であるゲル材料からなるので、血管の走行形状のような複雑な形状の生体組織をはじめとする任意の生体組織の形状を第1部材2によって模擬することができるという利点がある。
 また、第1部材2を構成するゲル材料は、乾燥等によって特性が変化するため長期保存には不向きであるが、第2部材3を構成する硬化した樹脂材料は、空気および湿気に対して安定な材料であり長期保存に適している。したがって、第1部材2全体を第2部材3によって覆い固めることで、蛍光材料の品質を維持しながら長期保存が可能な生体模擬試料1を提供することができるという利点がある。
In addition, since the first member 2 is made of a gel material that can be formed into an arbitrary shape, the shape of any living tissue including a living tissue having a complicated shape such as a traveling shape of a blood vessel Has the advantage of being able to simulate
In addition, although the gel material constituting the first member 2 is not suitable for long-term storage since the characteristics change due to drying etc., the cured resin material constituting the second member 3 is stable against air and moisture. Material and suitable for long-term storage. Therefore, covering the entire first member 2 with the second member 3 has an advantage of being able to provide the biological simulation sample 1 that can be stored for a long time while maintaining the quality of the fluorescent material.
 本実施形態においては、第1部材2が血管の走行形状を模擬することとしたが、これに代えて、他の生体組織の形状を模擬してもよい。
 例えば、図2に示されるように、第1部材2がリンパ管の形状を模擬していてもよく、胆管のような他の脈管の形状を模擬していてもよい。あるいは、図3に示されるように、第1部材2が腫瘍の形状を模擬していてもよい。
In the present embodiment, the first member 2 simulates the traveling shape of the blood vessel. However, instead of this, the shape of another living tissue may be simulated.
For example, as shown in FIG. 2, the first member 2 may simulate the shape of a lymphatic vessel and may simulate the shape of another vessel such as a bile duct. Alternatively, as shown in FIG. 3, the first member 2 may simulate the shape of a tumor.
 本実施形態においては、蛍光材料としてICGを用いることとしたが、蛍光材料の種類はこれに限定されるものではなく、他の種類の蛍光材料を用いてもよい。例えば、蛍光材料として、量子ドットまたはプロトポルフィリンIX(ppIX)を用いてもよい。
 臨床において、癌のような腫瘍組織の蛍光標識には、プロトポルフィリンIX(ppIX)が使用されることが多い。したがって、図3の腫瘍の形状を模擬した第1部材2には、臨床場面での腫瘍からの蛍光の見えにより近い見えを実現することができるように、ppIXを用いることが好ましい。
In the present embodiment, ICG is used as the fluorescent material, but the type of fluorescent material is not limited to this, and other types of fluorescent materials may be used. For example, quantum dots or protoporphyrin IX (ppIX) may be used as the fluorescent material.
In the clinic, protoporphyrin IX (ppIX) is often used for fluorescent labeling of tumor tissue such as cancer. Therefore, it is preferable to use ppIX for the first member 2 that simulates the shape of the tumor in FIG. 3 so as to achieve a closer look to the fluorescence from the tumor in the clinical setting.
 本実施形態においては、一層構造からなる第2部材3内に単一の第1部材2が配置されていることとしたが、第1部材2の数および第2部材3を構成する層の数は適宜変更することができる。
 例えば、図4Aおよび図4Bに示されるように、一層構造からなる第2部材3内の相互に異なる深さに、複数の第1部材21,22が配置されていてもよい。複数の第1部材21,22の形状は、相互に同一であってもよく、図4Aに示されるように、相互に異なっていてもよい。
In the present embodiment, although the single first member 2 is disposed in the second member 3 having a single-layer structure, the number of first members 2 and the number of layers constituting the second member 3 Can be changed as appropriate.
For example, as shown in FIGS. 4A and 4B, the plurality of first members 21 and 22 may be disposed at mutually different depths in the second member 3 having a single-layer structure. The shapes of the plurality of first members 21 and 22 may be identical to each other, or may be different from each other as shown in FIG. 4A.
 また、図5に示されるように、第2部材3が、2以上の層3a,3bが積層された層構造を有していてもよい。図5には、一例として、2層構造の第2部材3が示されている。
 血管やリンパ管、腫瘍等の周辺組織は、相互に異なる光散乱特性および光吸収特性を有する複数層からなる層構造を有する。第2部材3の層3a,3bは、周辺組織の各層(例えば、粘膜層や筋層)の光学特性を模擬するように、光散乱特性および光吸収特性のうち少なくとも一方において相互に異なっている。これにより、臨床場面での観察対象からの蛍光の見えにさらに近い見えを実現することができる。
Further, as shown in FIG. 5, the second member 3 may have a layered structure in which two or more layers 3 a and 3 b are stacked. The 2nd member 3 of 2 layer structure is shown by FIG. 5 as an example.
Surrounding tissues such as blood vessels, lymph vessels, and tumors have a layered structure composed of multiple layers having different light scattering properties and light absorption properties. The layers 3a and 3b of the second member 3 are different from each other in at least one of the light scattering property and the light absorption property so as to simulate the optical property of each layer (for example, the mucous layer and muscle layer) of the surrounding tissue. . This makes it possible to achieve an appearance closer to the appearance of fluorescence from the observation target in a clinical setting.
 具体的には、層3a,3bは、可視光の波長範囲において約0.1mm-1以上5mm-1以下の光散乱係数をそれぞれ有する。層3a,3bは、血液の吸収スペクトルを模擬した光吸収特性を有し、可視光の波長範囲において約0mm-1を超え20mm-1以下の光吸収係数をそれぞれ有する。深層側の層を模擬する層3bの光散乱係数および光吸収係数はそれぞれ、表面側の層を模擬する層3aの光散乱係数および光吸収係数よりも大きいことが好ましい。 Specifically, the layer 3a, 3b have respectively about 0.1 mm -1 or more 5 mm -1 or less of the light scattering coefficient in the wavelength range of visible light. The layers 3a and 3b have light absorption characteristics that simulate the absorption spectrum of blood, and each have a light absorption coefficient of more than about 0 mm -1 and 20 mm -1 or less in the visible light wavelength range. The light scattering coefficient and the light absorption coefficient of the layer 3b simulating the layer on the deep side are preferably larger than the light scattering coefficient and the light absorption coefficient of the layer 3a simulating the layer on the front surface, respectively.
 図5に示されるように第2部材3が複数の層3a,3bを有する場合、第1部材2は、一の層内にのみ配置されていてもよく、隣接する2つの層の間に配置されていてもよく、複数の層にまたがって配置されていてもよい。あるいは、各層3a,3b内に第1部材2が配置されていてもよい。 When the second member 3 has a plurality of layers 3a and 3b as shown in FIG. 5, the first member 2 may be disposed only in one layer, and is disposed between two adjacent layers. It may be provided, or may be disposed across multiple layers. Alternatively, the first member 2 may be disposed in each of the layers 3a and 3b.
1 生体模擬試料
2,21,22 第1部材
3 第2部材
3a,3b 層
1 living body simulation sample 2, 21, 22 first member 3 second member 3a, 3b layer

Claims (6)

  1.  蛍光材料を含み観察対象の生体組織の形状を模擬した第1部材と、
     該第1部材を覆い前記観察対象の生体組織の周辺組織の光学特性を模擬した第2部材とを備える生体模擬試料。
    A first member containing a fluorescent material and simulating the shape of a living tissue to be observed;
    And a second member that covers the first member and simulates the optical characteristics of the surrounding tissue of the living tissue to be observed.
  2.  前記第2部材は、2以上の層が積層された層構造を有し、
     前記2以上の層が、光散乱特性および光吸収特性のうち少なくとも一方において相互に異なる請求項1に記載の生体模擬試料。
    The second member has a layer structure in which two or more layers are stacked,
    The biological simulation sample according to claim 1, wherein the two or more layers differ from each other in at least one of light scattering properties and light absorption properties.
  3.  前記第1部材が、脈管の形状を模擬している請求項1または請求項2に記載の生体模擬試料。 The biological simulation sample according to claim 1 or 2, wherein the first member simulates the shape of a vessel.
  4.  前記第1部材が、血管の走行形状またはリンパ管の形状を模擬している請求項3に記載の生体模擬試料。 The biological simulation sample according to claim 3, wherein the first member simulates a traveling shape of a blood vessel or a shape of a lymphatic vessel.
  5.  前記蛍光材料が、インドシアニングリーンである請求項1から請求項4のいずれかに記載の生体模擬試料。 The biological simulation sample according to any one of claims 1 to 4, wherein the fluorescent material is indocyanine green.
  6.  前記第1部材が、蛍光材料を含むゲル材料からなり、
     前記第2部材が、硬化した樹脂材料からなり、
     前記第1部材が、前記第2部材内に包埋されている請求項1から請求項5のいずれかに記載の生体模擬試料。
    The first member is made of a gel material containing a fluorescent material,
    The second member is made of a cured resin material,
    The biological simulation sample according to any one of claims 1 to 5, wherein the first member is embedded in the second member.
PCT/JP2017/024533 2017-07-04 2017-07-04 Simulate biological sample WO2019008679A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2017/024533 WO2019008679A1 (en) 2017-07-04 2017-07-04 Simulate biological sample
PCT/JP2018/025179 WO2019009279A1 (en) 2017-07-04 2018-07-03 Simulated biological sample, endoscope evaluation system, and endoscope evaluation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2017/024533 WO2019008679A1 (en) 2017-07-04 2017-07-04 Simulate biological sample

Publications (1)

Publication Number Publication Date
WO2019008679A1 true WO2019008679A1 (en) 2019-01-10

Family

ID=64949999

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2017/024533 WO2019008679A1 (en) 2017-07-04 2017-07-04 Simulate biological sample
PCT/JP2018/025179 WO2019009279A1 (en) 2017-07-04 2018-07-03 Simulated biological sample, endoscope evaluation system, and endoscope evaluation method

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/025179 WO2019009279A1 (en) 2017-07-04 2018-07-03 Simulated biological sample, endoscope evaluation system, and endoscope evaluation method

Country Status (1)

Country Link
WO (2) WO2019008679A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020148533A (en) * 2019-03-12 2020-09-17 太平洋セメント株式会社 Method for evaluating unburnt carbon in coal ash

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013096920A (en) * 2011-11-02 2013-05-20 Hamamatsu Photonics Kk Fluorescent phantom device and fluorescent imaging method
WO2015037055A1 (en) * 2013-09-10 2015-03-19 株式会社島津製作所 Fluorescent image acquisition device
US20160310010A1 (en) * 2013-12-06 2016-10-27 Agency For Science, Technology And Research Method of imaging living tissue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5539841B2 (en) * 2010-10-26 2014-07-02 富士フイルム株式会社 Electronic endoscope system, processor device for electronic endoscope system, and method for operating electronic endoscope system
US10024785B2 (en) * 2015-06-19 2018-07-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Solid hemoglobin-polymer biophotonic phantoms and their use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013096920A (en) * 2011-11-02 2013-05-20 Hamamatsu Photonics Kk Fluorescent phantom device and fluorescent imaging method
WO2015037055A1 (en) * 2013-09-10 2015-03-19 株式会社島津製作所 Fluorescent image acquisition device
US20160310010A1 (en) * 2013-12-06 2016-10-27 Agency For Science, Technology And Research Method of imaging living tissue

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AKIYAMA, KOJI ET AL.: "Estimation of depth distribution of absorption by time-resolved measurement of backscattered light", IEICE TECHNICAL REPORT, vol. 102, no. 727, 11 March 2003 (2003-03-11), pages 1 - 4 *
ENOMOTO, TAKAHIRO ET AL.: "Fundamental study to realize optical imaging of arteriovenous fistula with PSF", IEICE TECHNICAL REPORT, vol. 114, no. 408, 15 January 2015 (2015-01-15), pages 105 - 109 *
HORINAKA, HIROMICHI ET AL.: "Detection of the target material in biological tissue by optically assisted ultrasonic velocity-change imaging method", JOURNAL OF MEDICAL ULTRASONICS, THE JAPAN SOCIETY OF ULTRASONICS IN MEDICINE, vol. 36, 15 April 2009 (2009-04-15), pages S292 *
SASAKI, HIROTAKA ET AL.: "Fundamental Study for reconstruction of in vivo fluorescent tomographic image using orthogonal function system", IEICE TECHNICAL REPORT, vol. 114, no. 515, 9 March 2015 (2015-03-09), pages 41 - 46 *
TANIGAWA, SHOHEI ET AL.: "Diagnosis device of vessel plaque using optically assisted ultrasonic velocity-change", EXTENDED ABSTRACTS OF THE 61ST JSAP SPRING MEETING, 2014, THE JAPAN SOCIETY OF APPLIED PHYSICS, 3 March 2014 (2014-03-03), pages 3 - 135 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020148533A (en) * 2019-03-12 2020-09-17 太平洋セメント株式会社 Method for evaluating unburnt carbon in coal ash
JP7197408B2 (en) 2019-03-12 2022-12-27 太平洋セメント株式会社 Evaluation method of unburned carbon in coal ash

Also Published As

Publication number Publication date
WO2019009279A1 (en) 2019-01-10

Similar Documents

Publication Publication Date Title
US10041831B2 (en) Fluorescent light phantom device and fluorescent light imaging method
US10024785B2 (en) Solid hemoglobin-polymer biophotonic phantoms and their use
US8539813B2 (en) Gel phantoms for testing cavitational ultrasound (histotripsy) transducers
Vardaki et al. Tissue phantoms for biomedical applications in Raman spectroscopy: a review
US20220082500A1 (en) Tissue phantoms
Samkoe et al. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision
Yang et al. Color-matched and fluorescence-labeled esophagus phantom and its applications
Schirillo We infer light in space
WO2019008679A1 (en) Simulate biological sample
Rudraiah et al. Bottom layer absorption coefficients extraction from two-layer phantoms based on crossover point in diffuse reflectance
Campbell et al. Monte Carlo modelling of photodynamic therapy treatments comparing clustered three dimensional tumour structures with homogeneous tissue structures
KR101334289B1 (en) Phantom apparatus with phantom of fluorescence performance for detection depth
Rudraiah et al. Diffused reflectance measurements to detect tattoo ink location in skin using the crossover point
Nunes et al. Appearance modelling of living human tissues
US8711355B2 (en) Method for evaluating performance characteristics of dental curing lights
Mamoshin et al. The study of the spectral characteristics of biological tissues for optimization of surgical lamp parameters
Grasso et al. Development of a morphologically realistic mouse phantom for pre‐clinical photoacoustic imaging
JP6890348B2 (en) Scale and kit with it
Gibson et al. Customizable optical tissue phantom platform for characterization of fluorescence imaging device sensitivity
WO2024192515A1 (en) Tissue phantoms
WO2017191670A1 (en) Phantom for imaging and evaluation method for optical imaging device
Patel Assessment of optical transmission and image contrast at infrared wavelengths using tissue simulating phantoms and biological tissues
KR102615423B1 (en) In vitro plaque model and the manufacturing method thereof
RU2389083C1 (en) Method of creation of model simulating optical properties of living biological tissues
Wu et al. Multispectral endoscopic imaging studies on the tissue components of gastrointestinal mucosa

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17916526

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17916526

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP